Smaller baseline brain volume and higher atrophy rate over two years is associated with poorer clinical outcomes: Post hoc analysis of the MS-STAT trial in secondary progressive MS

Authors
Category Primary study
JournalNeurology
Year 2015
This article has no abstract
Epistemonikos ID: e00d20b8a421d936cd07d5567834a56a02285b09
First added on: Feb 07, 2025